Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in International Public Health
Governance And Transparency At Pepfar, Matthew Kavanagh, Brook Baker
Governance And Transparency At Pepfar, Matthew Kavanagh, Brook Baker
Matthew M. Kavanagh
The US President's Emergency Plan for AIDS Relief (PEPFAR) has been one of the most effective foreign aid programmes in history. It reached 6·7 million people with antiretroviral therapy in 2013, and has also strengthened country health systems, provided billions of dollars in aid to biomedical and behavioural prevention programmes, and helped to drive declines in morbidity and mortality in many countries in sub-Saharan Africa. PEPFAR began as an emergency response, after relative inaction by wealthy nations, and rapidly built disease-response capacity by funding non-governmental organisations.
The Politics Of Transition & The Economics Of Hiv: Aids & Pepfar In South Africa, Matthew M. Kavanagh
The Politics Of Transition & The Economics Of Hiv: Aids & Pepfar In South Africa, Matthew M. Kavanagh
Matthew M. Kavanagh
AIDS poses a unique and unprecedented challenge to South Africa. The country has the largest HIV epidemic in the world—with 6.4 million people living with HIV—and one of the largest TB epidemics in the world as well. The country’s recent AIDS response has generated enormous optimism, both in South Africa and internationally. The biggest change, in many ways, has been political—dramatic shifts in ideology and motivation at the highest levels of government have moved the country from denialism and inaction to a bold national mobilization to bring anti-retroviral treatment to scale. Meanwhile, the approach of the U.S. government has evolved …
Pepfar’S Declining Investment In Treatment, Matthew Kavanagh, Marguerite Thorp
Pepfar’S Declining Investment In Treatment, Matthew Kavanagh, Marguerite Thorp
Matthew M. Kavanagh
Since its inception in 2003, the President’s Emergency Plan for AIDS Relief (PEPFAR) has saved millions of lives through providing anti-retroviral (ARV) treatment to people living with HIV/AIDS. However, our analysis of publicly available PEPFAR operational plans shows that funding to AIDS treatment has actually fallen significantly since 2008 in both absolute dollars and as a portion of total budgets—just at a pivotal moment when investment could change the course of the epidemic.